Blog
GLP-1 and GLP-2 and How They Differ
Table of Contents
GLP-1 and GLP-2, What Each One Does
GLP-1 and GLP-2 are two different gut hormones that come from the same parent molecule and then do almost nothing alike. GLP-1 handles appetite and blood sugar. GLP-2 maintains the lining of your intestine.
The reason people search for this is usually a specific mix-up. Tirzepatide targets two hormones, so it gets called a GLP-2. It is not one, and that confusion is worth clearing up before anything else.
GLP-1 and GLP-2 at a glance
Same origin, different destination. The GLP-1 and GLP-2 comparison fits in one table.
| GLP-1 | GLP-2 | |
| Where it comes from | Cells in the intestine, released after you eat | The same cells, released at the same time |
| Parent molecule | Proglucagon | Proglucagon, the same one |
| Main target | Brain, pancreas and stomach | The intestinal lining itself |
| Main job | Signals fullness, slows stomach emptying, supports insulin release | Supports growth and repair of the gut lining and nutrient absorption |
| Used in medicine for | Type 2 diabetes and weight management | Specific intestinal conditions, such as short bowel syndrome |
| Role in weight loss | The basis of this class of medication | None established |
| Does AHC prescribe it | Yes, as compounded semaglutide and tirzepatide | No |
If the first column is what you came for, the guide to what a GLP-1 medication does covers it in more depth than this comparison does.
What GLP-1 does
Of GLP-1 and GLP-2, GLP-1 is the one behind the medications people know.
- Signals fullness. It acts on receptors in the brain that influence appetite and satisfaction after eating.
- Slows stomach emptying. Food stays in the stomach longer, so fullness lasts longer after a meal.
- Supports insulin release. It prompts insulin when blood sugar is elevated, and lowers glucagon after eating.
- Clears within minutes. Natural GLP-1 is broken down almost immediately, which is why the medications were engineered to last far longer.
Those four effects are why GLP-1 became a target for treatment and GLP-2 did not. Nothing about GLP-2 lends itself to appetite control, which is the practical reason the two hormones ended up in completely different areas of medicine.
What GLP-2 does
The other half of GLP-1 and GLP-2 works on the gut itself rather than on how much you eat.
- Maintains the intestinal lining. It supports the growth and repair of the tissue that absorbs your food.
- Strengthens the gut barrier. The lining is what keeps intestinal contents where they belong.
- Improves absorption. It helps the intestine take up nutrients and fluids more effectively.
- Increases intestinal blood flow. More blood to the gut supports all of the above.
Medications that mimic GLP-2 exist, and they are prescribed for people who have lost a significant amount of functioning intestine or cannot absorb enough nutrients. They are not weight loss medications and AHC does not offer them.
GLP-1, GLP-2 and GIP side by side
Three hormones get mixed up in this conversation, and adding the third one makes the picture clearer rather than messier.
| GLP-1 | GLP-2 | GIP | |
| What it is | A gut hormone released after eating | A gut hormone released at the same time | A separate gut hormone released after eating |
| Main effect | Fullness, slower stomach emptying, insulin support | Growth and repair of the intestinal lining | Influences insulin and appetite through a different route |
| Used in weight medication | Yes, it is the main target | No | Yes, alongside GLP-1 in tirzepatide |
| Which AHC product | Compounded semaglutide and tirzepatide | None | Compounded tirzepatide |
Read across the bottom row and the confusion disappears. Tirzepatide sits under GLP-1 and GIP. Nothing in the AHC range sits under GLP-2, and nothing in the weight management field does either.
Why the mix-up matters
Getting GLP-1 and GLP-2 straight is not academic. It affects what you might be sold.
- Numbers imply upgrades. A product labeled GLP-2 or GLP-3 sounds newer than a GLP-1, which is exactly why the labels get used.
- Price follows the label. Something positioned as the next generation can be priced as though it is, without being anything of the kind.
- It obscures what you are taking. If you cannot name the active ingredient and the pathway, you cannot check anything about it.
- It makes real questions harder. A clinician can answer a question about semaglutide or tirzepatide. Nobody can answer a question about a GLP-3.
The reliable test is the active ingredient rather than the number. Everything else on a label is a description someone chose to write, and in this corner of the market those descriptions are doing a lot of work.
Why tirzepatide is not a GLP-2
This is the misunderstanding that sends most people searching for GLP-1 and GLP-2 in the first place.
| What people think | What is true |
| GLP-2 means two GLP hormones | It means glucagon-like peptide-2, a specific separate hormone. The number is a name, not a count |
| Tirzepatide is a GLP-2 medication | Tirzepatide targets GLP-1 and GIP. GIP is a different hormone again, and neither of them is GLP-2 |
| GLP-3 is the next hormone up | There is no GLP-3 hormone. It is internet shorthand for an experimental medication that targets three pathways |
| A higher number means a stronger drug | The numbers come from the order the hormones were identified, not from potency |
| GLP-2 is the next step after GLP-1 for weight loss | GLP-2 has no established role in weight management at all |
Tirzepatide being a dual agonist is the root of it. Targeting two hormones is not the same as being hormone number two. There is more on how it works in the guide to what tirzepatide is.
Where the GLP-1 and GLP-2 numbers come from
The naming of GLP-1 and GLP-2 is historical rather than a ranking, and knowing that removes most of the confusion.
- Both hormones are cut from the same parent protein, proglucagon, by the same cells
- The numbers reflect the order in which researchers identified them
- They are released together after a meal, then act on completely different tissues
- A medication targeting more pathways is described as a dual or triple agonist, never as GLP-2 or GLP-3
So GLP-1 and GLP-2 are siblings rather than versions. One is not an upgrade on the other, in the same way that a kidney is not an upgraded liver. They were simply named in the order they were found.
Does GLP-2 have any role in weight management
Not currently, and it would be dishonest to imply otherwise. This is the sharpest practical difference between GLP-1 and GLP-2.
- No approved use. GLP-2 medications are approved for intestinal conditions, not for obesity or weight management.
- The mechanism points the other way. Better nutrient absorption is the opposite of what a weight loss medication is usually trying to achieve.
- Research is early. Scientists are still working out how the proglucagon hormones interact. Early research is not a treatment.
- Be careful what you are sold. Anything marketed as a GLP-2 for weight loss is making a claim that current evidence does not support.
If a seller is using the GLP-2 label to suggest something newer or stronger than a GLP-1, that is a marketing choice rather than a clinical one, and it is worth treating as a warning rather than a feature.
Which of these AHC prescribes
Of GLP-1 and GLP-2, AHC works with the first one only.
| Medication | What it targets | What it is for |
| Compounded semaglutide | GLP-1 receptors | Medically guided weight loss, after a provider review |
| Compounded tirzepatide | GLP-1 and GIP receptors | Medically guided weight loss, after a provider review |
| Any GLP-2 medication | GLP-2 receptors | Not offered by AHC. Prescribed elsewhere for intestinal conditions |
Both AHC options are formulated as the GLP-1 medication plus Vitamin B12 in a single vial. You can read more about compounded tirzepatide, and a licensed provider reviews every order and retains full discretion to approve or decline.
Compounded medications are prepared by state-licensed compounding pharmacies. They are not FDA-approved and have not been reviewed by the FDA for safety, efficacy, or quality.
Questions support hears about GLP-1 and GLP-2
The same handful of questions come up, and they are worth answering in one place.
| The question | The short answer |
| Am I on a GLP-2 without realizing it | No. AHC prescribes compounded semaglutide and compounded tirzepatide, and neither targets GLP-2 |
| Should I switch to a GLP-2 | There is nothing to switch to. GLP-2 medications treat intestinal conditions, not weight |
| Is tirzepatide the upgrade from semaglutide | It targets an extra pathway. Which suits you is a provider decision, not a ranking |
| My friend says they are on a GLP-3 | No GLP-3 hormone exists. Ask them for the active ingredient and it will resolve itself |
| Does GLP-2 explain my digestive side effects | Unlikely. Those relate to how GLP-1 medication slows stomach emptying |
Anything about your own treatment goes to AHC support through live chat or [email protected], where the medical officer reviews clinical questions.
How to check what you are taking
If you are unsure where your treatment sits between GLP-1 and GLP-2, four checks settle it.
- Look at the active ingredient. Semaglutide is a GLP-1 receptor agonist. Tirzepatide targets GLP-1 and GIP. Neither is a GLP-2.
- Ignore the marketing number. GLP-2 and GLP-3 used as product labels are a sign to ask more questions, not fewer.
- Check what it is prescribed for. A GLP-2 medication is prescribed for intestinal conditions. If it is being sold to you for weight loss, something is wrong.
- Ask your provider directly. At AHC that means contacting support through live chat or [email protected], and the medical officer reviews clinical questions.
Considering treatment? The free BMI calculator is a starting point, though a number never decides this on its own. A licensed provider reviews every order. Begin your evaluation when you are ready.
The short version. GLP-1 and GLP-2 come from the same parent molecule and then do different jobs. GLP-1 handles appetite and blood sugar. GLP-2 maintains the gut lining and has no established weight loss role. Tirzepatide is a GLP-1 and GIP medication, not a GLP-2.
Frequently asked questions
What is the difference between GLP-1 and GLP-2?
GLP-1 and GLP-2 are both gut hormones cut from the same parent molecule. GLP-1 signals fullness, slows stomach emptying and supports insulin release. GLP-2 maintains the intestinal lining and helps absorption.
Is tirzepatide a GLP-2 medication?
No. Tirzepatide targets GLP-1 and GIP receptors. Targeting two hormones is not the same as being hormone number two.
Does GLP-2 help with weight loss?
No established role. GLP-2 medications are approved for intestinal conditions, and better nutrient absorption is not what a weight loss medication aims for.
Is there a GLP-3 hormone?
No. GLP-3 is internet shorthand for an experimental medication that targets three hormone pathways. It is not a hormone and it is not available at AHC.
Why are they numbered 1 and 2?
The numbers reflect the order researchers identified them, not their strength or a sequence of treatments.
Do GLP-1 and GLP-2 come from the same place?
Yes. Both are produced by the same intestinal cells from the same parent protein, proglucagon, and released together after a meal.
Does AHC offer a GLP-2 medication?
No. AHC prescribes compounded semaglutide, which targets GLP-1, and compounded tirzepatide, which targets GLP-1 and GIP.
Is a GLP-2 stronger than a GLP-1?
The question does not apply to GLP-1 and GLP-2. They act on different tissues for different purposes, so one is not a stronger version of the other.
What is GIP then?
A separate gut hormone that also influences insulin and appetite. Tirzepatide targets it alongside GLP-1, which is why it is called a dual agonist.
Should I be worried if something is sold to me as a GLP-2 for weight loss?
Treat it as a reason to ask questions. GLP-2 has no established weight management role, so the label is doing marketing work rather than clinical work.
Can GLP-2 medications be used off-label for weight?
That is a question for a prescribing clinician, not a web page. AHC does not offer GLP-2 medications in any form.
Do GLP-1 and GLP-2 cause the same side effects?
No. They act on different tissues, so their effects and their side effects differ. The digestive symptoms people describe on treatment relate to GLP-1 slowing stomach emptying.
Where can I see which pathway my AHC medication targets?
Your product page states the active ingredient, and support can confirm it. Semaglutide targets GLP-1, and tirzepatide targets GLP-1 and GIP.
Which one of GLP-1 and GLP-2 does my semaglutide work on?
GLP-1 receptors. If you are unsure what your treatment targets, contact AHC support and the medical officer will confirm it.
Still unsure? Book a provider consultation for $29.99, or contact AHC support through live chat on the website or at [email protected].
Medical Disclaimer
Compounded medications are prepared by state-licensed compounding pharmacies. They are not FDA-approved and have not been reviewed by the FDA for safety, efficacy, or quality. Results vary by individual and depend on adherence, clinical guidance, and lifestyle factors. This content is for informational purposes only and is not medical advice. Clinical services are provided by independently contracted, U.S.-licensed clinicians. Speak with a licensed provider about your individual situation. If you experience severe symptoms, seek medical care. For questions about your treatment, contact AHC support through live chat on the website or at [email protected]